CM

Chaithanya Manjula Rajasekar

Active Director Director DIN 10588247
DIN 10588247 First appointment Apr 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Chaithanya Manjula Rajasekar

Data last updated:

Chaithanya Manjula Rajasekar is a Director at Sai Pharmed Private Limited (since 2024) and Director at Invisat Pharmaceuticals (Opc) Private Limited (since 2024). The companies operate in Paper.

DIN 10588247
Primary Designation Director
Industry Paper
First Appointment 11 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sai Pharmed Private Limited U46497TN2024PTC174571
Director08 Nov 20242024Active
Director11 Apr 20242024Active

Board colleagues of Chaithanya Manjula Rajasekar

Directorship timeline

Open interactive timeline →
Sai Pharmed Private Limited
Invisat Pharmaceuticals (Opc) Private Limited
Premium access

Shareholding and investment profile for Chaithanya Manjula Rajasekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chaithanya Manjula Rajasekar

Chaithanya Manjula Rajasekar currently holds 2 directorships: Sai Pharmed Private Limited (Director, since 08 Nov 2024); Invisat Pharmaceuticals (Opc) Private Limited (Director, since 11 Apr 2024).

Chaithanya Manjula Rajasekar was first appointed on 11 Apr 2024 as Director at Invisat Pharmaceuticals (Opc) Private Limited.

The current boards of Chaithanya Manjula Rajasekar's companies include Rajasekar Baba Seshadri (Sai Pharmed Private Limited), Vaduvapalli Manjula (Sai Pharmed Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available